• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical characteristics and treatment strategy of nocardiosis in lung transplant recipients: A single-center experience.肺移植受者诺卡菌病的临床特征及治疗策略:单中心经验
IDCases. 2023 Mar 31;32:e01758. doi: 10.1016/j.idcr.2023.e01758. eCollection 2023.
2
Nocardia prophylaxis, treatment, and outcomes of infection in lung transplant recipients: A matched case-control study.肺移植受者中诺卡菌感染的预防、治疗和结局:一项匹配病例对照研究。
Transpl Infect Dis. 2021 Apr;23(2):e13478. doi: 10.1111/tid.13478. Epub 2020 Oct 13.
3
Central nervous system nocardiosis diagnosed by metagenomic next-generation sequencing: A case series and literature review.宏基因组下一代测序诊断中枢神经系统奴卡菌病:病例系列及文献复习。
Adv Clin Exp Med. 2023 Dec;32(12):1453-1463. doi: 10.17219/acem/175818.
4
Nocardia infection in lung transplant recipients.肺移植受者的诺卡菌感染
J Heart Lung Transplant. 2002 Mar;21(3):354-9. doi: 10.1016/s1053-2498(01)00394-1.
5
Risk factors and prophylaxis for nocardiosis in solid organ transplant recipients: A nested case-control study.实体器官移植受者诺卡菌病的危险因素及预防:一项巢式病例对照研究。
Clin Transplant. 2023 Sep;37(9):e15016. doi: 10.1111/ctr.15016. Epub 2023 May 11.
6
Pulmonary nocardiosis with bloodstream infection diagnosed by metagenomic next-generation sequencing in a kidney transplant recipient: A case report.通过宏基因组二代测序诊断肾移植受者合并血流感染的肺诺卡菌病:一例报告
World J Clin Cases. 2023 Mar 6;11(7):1634-1641. doi: 10.12998/wjcc.v11.i7.1634.
7
Trimethoprim/sulfamethoxazole for nocardiosis in solid organ transplant recipients: Real-life data from a multicentre retrospective study.复方磺胺甲噁唑治疗实体器官移植受者诺卡菌病:多中心回顾性研究的真实数据。
Transpl Infect Dis. 2021 Aug;23(4):e13669. doi: 10.1111/tid.13669. Epub 2021 Jul 8.
8
Metagenomic next-generation sequencing provides prognostic warning by identifying mixed infections in nocardiosis.宏基因组下一代测序通过鉴定诺卡氏菌感染中的混合感染提供预后警示。
Front Cell Infect Microbiol. 2022 Aug 31;12:894678. doi: 10.3389/fcimb.2022.894678. eCollection 2022.
9
Clinical characteristics of hospitalized patients with Nocardia genus detection by metagenomic next generation sequencing in a tertiary hospital from southern China.中国南方一家三甲医院采用宏基因组下一代测序检测诺卡氏菌属住院患者的临床特征。
BMC Infect Dis. 2023 Nov 8;23(1):772. doi: 10.1186/s12879-023-08615-z.
10
Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.造血干细胞移植受者诺卡菌感染:欧洲血液和骨髓移植学会传染病工作组的一项多中心国际回顾性研究。
Clin Infect Dis. 2022 Aug 24;75(1):88-97. doi: 10.1093/cid/ciab866.

引用本文的文献

1
Investigation of Risk Factors and Development of Clinical Prediction Model for Nocardiosis in Lung Transplant Recipients.肺移植受者诺卡菌病危险因素调查及临床预测模型的建立
Infect Drug Resist. 2025 Sep 2;18:4527-4537. doi: 10.2147/IDR.S536103. eCollection 2025.
2
Clinical Features of Pulmonary Nocardiosis and Diagnostic Value of Metagenomic Next-Generation Sequencing: A Retrospective Study.肺诺卡菌病的临床特征及宏基因组下一代测序的诊断价值:一项回顾性研究
Pathogens. 2025 Jul 2;14(7):656. doi: 10.3390/pathogens14070656.
3
infection presenting as a solitary bronchial neoplasm in an immunocompetent adult: a case report.免疫功能正常的成年人中表现为孤立性支气管肿瘤的感染:一例报告
Front Med (Lausanne). 2024 Jan 10;10:1337303. doi: 10.3389/fmed.2023.1337303. eCollection 2023.

本文引用的文献

1
Metagenomic Next-Generation Sequencing for Diagnosing Infections in Lung Transplant Recipients: A Retrospective Study.宏基因组下一代测序在肺移植受者感染诊断中的应用:一项回顾性研究。
Transpl Int. 2022 Feb 10;35:10265. doi: 10.3389/ti.2022.10265. eCollection 2022.
2
Clinical Analysis of Metagenomic Next-Generation Sequencing Confirmed Pneumonia: A Case Series and Literature Review.宏基因组下一代测序确诊肺炎的临床分析:病例系列及文献综述
Infect Drug Resist. 2021 Apr 16;14:1481-1492. doi: 10.2147/IDR.S305790. eCollection 2021.
3
Nocardia prophylaxis, treatment, and outcomes of infection in lung transplant recipients: A matched case-control study.肺移植受者中诺卡菌感染的预防、治疗和结局:一项匹配病例对照研究。
Transpl Infect Dis. 2021 Apr;23(2):e13478. doi: 10.1111/tid.13478. Epub 2020 Oct 13.
4
Update on Nocardia infections in solid-organ transplantation.实体器官移植中诺卡菌感染的研究进展。
Curr Opin Organ Transplant. 2020 Aug;25(4):383-392. doi: 10.1097/MOT.0000000000000793.
5
Development of the organ donation and transplantation system in China.中国器官捐献与移植体系的发展
Chin Med J (Engl). 2020 Apr 5;133(7):760-765. doi: 10.1097/CM9.0000000000000779.
6
Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis.宏基因组下一代测序在混合性肺部感染诊断中的应用。
BMC Pulm Med. 2019 Dec 19;19(1):252. doi: 10.1186/s12890-019-1022-4.
7
Nocardia infections in solid organ transplantation: Guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation.实体器官移植中的诺卡菌感染:美国移植学会实践感染病学组指南。
Clin Transplant. 2019 Sep;33(9):e13509. doi: 10.1111/ctr.13509. Epub 2019 Mar 19.
8
Clinical features, identification, antimicrobial resistance patterns of Nocardia species in China: 2009-2017.中国诺卡氏菌属的临床特征、鉴定及抗菌药物耐药模式:2009-2017 年。
Diagn Microbiol Infect Dis. 2019 Jun;94(2):165-172. doi: 10.1016/j.diagmicrobio.2018.12.007. Epub 2018 Dec 29.
9
Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice.宏基因组下一代测序在临床应用中的微生物诊断性能。
Clin Infect Dis. 2018 Nov 13;67(suppl_2):S231-S240. doi: 10.1093/cid/ciy693.
10
Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study.实体器官移植后诺卡菌病的结局与治疗:一项欧洲研究的新见解
Clin Infect Dis. 2017 May 15;64(10):1396-1405. doi: 10.1093/cid/cix124.

肺移植受者诺卡菌病的临床特征及治疗策略:单中心经验

Clinical characteristics and treatment strategy of nocardiosis in lung transplant recipients: A single-center experience.

作者信息

Xu Yu, Lian Qiao-Yan, Chen Ao, Zhang Jian-Heng, Xu Xin, Huang Dan-Xia, He Jian-Xing, Ju Chun-Rong

机构信息

State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.

Department of Thoracic Surgery, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.

出版信息

IDCases. 2023 Mar 31;32:e01758. doi: 10.1016/j.idcr.2023.e01758. eCollection 2023.

DOI:10.1016/j.idcr.2023.e01758
PMID:37092136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10119885/
Abstract

OBJECTIVE

are infrequent pathogens that disproportionately afflict organ transplant recipients. The present study aimed to summarize the clinical manifestations, diagnostic approaches, and treatment strategies of nocardiosis in lung transplant recipients.

METHODS

This retrospective study reviewed the clinical data of adult lung transplant recipients who were complicated with nocardiosis between January 2018 and December 2021 at the largest lung transplant center in South China.

RESULTS

The incidence of nocardiosis was 4.2% (13/316), including 9 cases of pulmonary nocardiosis and 4 disseminated nocardiosis (blood, pulmonary and intracranial). The accuracy in diagnosing nocardiosis was 77.8% by culture and 100% by metagenomic next-generation sequencing (mNGS). was the most common causative pathogen. Trimethoprim-sulfamethoxazole-based combination therapy was administered initially, followed by a single antibiotic as the maintained therapy, lasting for 4-8 months.

CONCLUSIONS

mNGS is more accurate than culture in diagnosing nocardiosis. Most patients responded well to the antibiotic therapy with combined antibiotics at the initial stage followed by a single antibiotic treatment.

摘要

目的

是罕见病原体,对器官移植受者造成的影响不成比例。本研究旨在总结肺移植受者诺卡菌病的临床表现、诊断方法和治疗策略。

方法

这项回顾性研究回顾了2018年1月至2021年12月在中国南方最大的肺移植中心发生诺卡菌病的成年肺移植受者的临床资料。

结果

诺卡菌病的发病率为4.2%(13/316),包括9例肺诺卡菌病和4例播散性诺卡菌病(血液、肺和颅内)。通过培养诊断诺卡菌病的准确率为77.8%,通过宏基因组下一代测序(mNGS)的准确率为100%。是最常见的致病病原体。最初给予基于甲氧苄啶-磺胺甲恶唑的联合治疗,随后用单一抗生素作为维持治疗,持续4-8个月。

结论

mNGS在诊断诺卡菌病方面比培养更准确。大多数患者在初始阶段接受联合抗生素治疗,随后接受单一抗生素治疗时对抗生素治疗反应良好。